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Abstract
Background
Norovirus is a leading cause of gastroenteritis episodes and outbreaks in US military
deployments, but estimates of endemic disease burden among military personnel in garri-
son are lacking.
Methods
Diagnostic codes from gastroenteritis-associated medical encounters of active duty military
personnel and their beneficiaries from July 1998–June 2011 were obtained from the Armed
Forces Health Surveillance Center. Using time-series regression models, cause-unspeci-
fied encounters were modeled as a function of encounters for specific enteropathogens.
Model residuals (representing unexplained encounters) were used to estimate norovirus-
attributable medical encounters. Incidence rates were calculated using population data for
both active duty and beneficiary populations.
Results
The estimated annual mean rate of norovirus-associated medically-attended visits among
active duty personnel and their beneficiaries was 292 (95% CI: 258 to 326) and 93 (95% CI:
80 to 105) encounters per 10,000 persons, respectively. Rates were highest among benefi-
ciaries <5 years of age with a median annual rate of 435 (range: 318 to 646) encounters per
10,000 children. Norovirus was estimated to cause 31% and 27% of all-cause gastroenteri-
tis encounters in the active duty and beneficiary populations, respectively, with over 60%
occurring between November and April. There was no evidence of any lag effect where nor-
ovirus disease occurred in one population before the other, or in one beneficiary age group
before the others.
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Conclusions
Norovirus is a major cause of medically-attended gastroenteritis among non-deployed US
military active duty members as well as in their beneficiaries.
Introduction
Noroviruses are a major cause of epidemic and sporadic gastroenteritis worldwide [1–4]. In the
United States, norovirus is estimated to cause 19–21 million episodes of gastroenteritis, 1.7–1.9
million medical outpatient visits, 400,000 emergency department visits, 56,000–71,000 hospi-
talizations, and 570–800 deaths annually [2, 5–8]. The total annual health care and social costs
for norovirus disease in the US have been estimated at $5.5 billion [9]. However, the lack of a
widely used, rapid and sensitive clinical assay has made detailed characterizations of norovirus
activity, impact, and burden challenging in the range of settings where they cause disease.
Norovirus outbreaks are common among groups inhabiting relatively confined spaces such
as nursing homes, daycares, cruise liners, and military settings such as barracks and ships. In
military populations, numerous outbreaks of norovirus gastroenteritis have been documented
among troops deployed in support of Operations Iraqi and Enduring Freedom, on ships, as
well as among recruit training populations [10]. However, estimates of disease incidence and
burden have not been published for this population.
Efforts to characterize the norovirus disease burden in military settings face the same chal-
lenges seen in civilian settings, such that methodological approaches developed for civilian
populations can be used to study the US military and their beneficiary populations [11]. Given
the potential health burden of norovirus in military populations [10], impact on mission-readi-
ness and training [12], and long-term sequelae [13, 14], efforts to better understand disease
incidence are warranted, especially in the context of vaccine development.
This study utilized a time-series regression approach to estimate the incidence of norovirus-
attributable disease based on medical encounter data from US Department of Defense (DoD)
populations seeking care for acute gastroenteritis. We generated incidence estimates for both
active duty populations and their dependent beneficiaries (e.g. spouses and children).
Methods
Data Sources
Our study populations were all active duty (AD) military personnel and their dependent bene-
ficiaries (DB) who sought medical care in weeks with start dates between July 5, 1998 to June
26, 2011 or July 1, 2001 to June 26, 2011, respectively. Medical claims data including encoun-
ters at DoD and non-DoD medical treatment facilities from the Standard Ambulatory Data
Record (SADR), Standard Inpatient Data Record (SIDR), Health Care Service Records
(HCSR), TRICARE Encounter Data (TED), and the Tri-Service Reportable Events Database
were supplied by the Armed Forces Health Surveillance Center (AFHSC) [15, 16]. The study
protocol was approved by the Naval Medical Research Center Institutional Review Board in
compliance with all applicable Federal regulations governing the protection of human subjects;
informed consent was not required for our analyses. To prevent duplication of records, report-
able events were compared with documented medical encounters in the SIDR and SADR data-
bases. If an event was documented in both datasets within 7 days, only a single observation was
retained.
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We extracted data for all gastroenteritis-associated medical encounters as identified by diag-
nosis codes (International Classification of Diseases, Ninth Revision, Clinical Modification
[ICD9-CM]; Table 1) recorded in the first or second diagnostic position. Data were organized
into weekly counts of bacterial, viral, protozoal and cause-unspecified encounters. Total
monthly AD and yearly DB enrollment data were obtained from the Defense Manpower Data
Center (DMDC) and used to estimate population-based rates of inpatient and outpatient
encounters.
Statistical Analyses
Because norovirus is rarely laboratory-confirmed and is underrepresented in ICD9-CM-coded
diagnoses [17], our goal was to estimate norovirus-attributable medical encounters among the
cause-unspecified gastroenteritis-associated encounters for both AD and DB populations. We
used a previously developed [6–8, 18–20] time-series regression approach to model the weekly
number of cause-unspecified codes as a function of cause-specified codes, assuming counts of
cause-unspecified codes follow a Poisson distribution. Cause-specified encounters were
Table 1. Pathogen-based categories of diagnostic codes used to identify gastroenteritis-associated
medical encounters, supplied by the United States Armed Forces Health Surveillance Center, July
1998–June 2011.
Pathogen Category and Diagnoses ICD-9-CM* Code(s)
Cause unspeciﬁed
Infectious colitis, enteritis, and gastroenteritis 009.0
Colitis, enteritis, and gastroenteritis of presumed infectious origin 009.1
Infectious diarrhea 009.2
Diarrhea of presumed infectious origin 009.3
Presumed noninfectious 558.1–558.9
Symptom: Diarrhea NOS 787.91
Other viral enteritis 008.64–008.69
Intestinal infection due to other organism not elsewhere classiﬁed 008.8
Rotavirus 008.61
Adenovirus 008.62
Norovirus (Norwalk) 008.63
Bacterial
Cholera 001 (all subgroups)
Typhoid/Paratyphoid 002.0–002.9
Salmonella 003.0–003.9
Shigella 004 (all subgroups)
Vibrio parahaemolyticus 005.4
Escherichia coli 008.0
Campylobacter 008.43
Yersinia 008.44
Clostridium difﬁcile 008.45
Other/unspeciﬁed bacteria 008.1–008.5
Other bacterial food poisoning 005.0–005.9
Protozoal
Ameba 006.0–006.2; 006.9
Other protozoal 007 (all subgroups)
*International Classiﬁcation of Diseases, Ninth Revision, Clinical Modiﬁcation
doi:10.1371/journal.pone.0148505.t001
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grouped by pathogen-based categories, including rotavirus, adenovirus, norovirus, bacterial,
and protozoal-coded encounters (Table 1). We calculated the number of unspecified gastroen-
teritis encounters by summing encounters coded as unspecified gastroenteritis/diarrhea and
other viral gastroenteritis. Similar to previous approaches [6, 7], presumed noninfectious
coded encounters were included as unspecified due to the likelihood that episodes of gastroen-
teritis without a known etiology are often misclassified as such. We assumed that among the
cause-unspecified gastroenteritis/diarrhea encounters, weekly encounters due to a specific
pathogen group were proportional to the encounters coded for that pathogen group in that
week.
Beneficiaries were modeled separately by age group (all ages, 0–4, 5–17, 18–39, 40–64
years). The65-year DB age group was included only in the model for “all ages” due to small
numbers (<0.1% of DB encounters). Active duty members were initially modeled as one com-
bined age group. The model can be expressed by the formula:
EðCUx;yÞ ¼ aþ ðb1  Bactx;yÞ þ ðb2  Protox;yÞ þ ðb3  Rotax;yÞ þ ðg TimeyÞ þ ðd FedÞ
where CU, Bact, Proto, and Rota are the counts of diagnostic codes in the cause-unspeciﬁed,
bacterial, protozoal, and rotavirus categories, respectively (Table 1), for age group x and week
y. Adenovirus-speciﬁc diagnostic code counts were not included in the model due to small
numbers that showed no clear seasonal pattern. α represents the number of background, asea-
sonal encounters not explained by any pathogen-coded categories, Time is a sequential variable
for the week of the coded encounter included to account for any secular trends, and Fed is the
categorical variable accounting for weeks that included a federal holiday, accounting for
decreased medical encounters in these weeks, similar to an approach taken previously [21, 22].
Poisson models were ﬁtted using robust standard errors to account for overdispersion in the
outcome variable.
The number of medical encounters not explained by the model (i.e., the model residuals)
exhibited winter seasonality consistent with known norovirus epidemiology. These residuals
were used to estimate the number of norovirus encounters by taking the difference between the
weekly residual and the minimum weekly residual for a given seasonal year (July through June
of the following calendar year). This assumed that any seasonality in unspecified visits not
explained by the model were due to norovirus, and that no norovirus visits took place during
the week with the minimum residual for each seasonal year. Rates of norovirus-associated
medical encounters were estimated by seasonal year using annual enrollment data and
expressed as the number of encounters per 10,000 persons. Coded norovirus-encounters,
although captured in the data (Table 1), were not included in the estimated norovirus-attribut-
able counts due to small numbers (mean of<40 encounters per seasonal year in both AD and
DB populations; Table 2).
Additional exploratory analyses were performed. We explored whether younger recruits
(representing newly enlisted personnel) had a higher incidence of norovirus by building sepa-
rate models for<20 year-old and40 year-old age groups in the AD population. In addition,
weekly counts of encounters were collapsed into monthly counts, and models were refit to
assess the sensitivity of the temporal grouping. To visualize any seasonal patterns among differ-
ent age groups, norovirus-attributable encounters were averaged by the week number of the
seasonal year over each population’s respective study period, and plotted using a 5-week mov-
ing average. Finally, we investigated age-related temporal differences in predicted norovirus
activity by calculating lagged correlation coefficients among the predicted norovirus time-
series DB age groups; lagged correlations coefficients were also calculated between AD and DB
populations.
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Results
Between July 1998 and June 2011, there were 1,758,562 gastroenteritis medical encounters
among the AD population, for a mean of 135,274 visits per seasonal year (Fig 1; Table 2).
Among the DB population, in July 2001–June 2011, there were 1,797,140 gastroenteritis medi-
cal encounters, for a mean of 179,714 visits per seasonal year. The great majority of these were
outpatient encounters, with 99.1% and 98.0% among the AD and DB populations, respectively.
Among beneficiaries presenting with all-cause gastroenteritis, over 96% were less than 40 years
of age, with 54% in the 0–4 year age group (Table 3). Denominator data used to calculate rates
were stable over the study periods, with AD and DB enrollment ranging from ~1,390,000–
1,470,000 and ~5,160,000–5,400,000 persons per seasonal year, respectively.
The bacterial category was significantly associated with cause-unspecified gastroenteritis in
all models (see Table A in S1 File for model coefficients). The protozoal category was not sig-
nificant in three models, and three models yielded a protozoal coefficient that was negative.
The rotavirus category was significant in all models except in the 18–39 year age group; the 40–
64 year age group model yielded a rotavirus coefficient that was negative. Since the coefficients
of these protozoal and/or rotavirus variables were small in the models in which they were either
negative or non-significant, removing them did not affect estimated norovirus encounters by
more than 3% over the entire study periods. As a result, protozoal and rotavirus variables were
retained to maintain a consistent approach across all models.
Weekly estimates of norovirus visits exhibited winter seasonality in both AD and DB popu-
lations (Fig 1). For the AD population, we estimated ~540,000 cause-unspecified encounters
were attributable to norovirus over 13 seasonal years (July 1998–June 2011), corresponding to
a mean of 292 (95% CI: 258 to 326) visits per 10,000 persons, ranging from 168–387 encounters
per 10,000 persons by seasonal year (Tables 3 & 4, Fig 2). For the DB population, we estimated
~490,000 cause-unspecified coded encounters were attributable to norovirus over 10 seasonal
years (July 2001–June 2011), corresponding to a mean of 93 (95% CI: 80 to 105) visits per
10,000 persons, ranging from 66–139 encounters per 10,000 persons by seasonal year. Esti-
mated norovirus-attributable visits accounted for 30.7% and 27.2% of all-cause gastroenteritis
encounters in the AD and DP all ages populations, respectively, with over 60% occurring in
from November to April in both the AD (66.6%) and DB all ages (61.6%) populations. The
majority of the estimated norovirus visits in the beneficiary population occurred in the 0–4 age
group (>50%; Table 3), with seasonal estimates ranging from 318 to 646 visits per 10,000
Table 2. Codedmedical encounters by population and cause category.
Cause Encounters by Active Duty Members (July 1998–June 2011) Encounters by Dependent Beneﬁciaries (July 2001–June
2011)
N Seasonal Year* Mean
No. (%)
Encounters per 10,000
Persons
N Seasonal Year* Mean
No. (%)
Encounters per 10,000
Persons
Cause unspeciﬁed 1,732,903 133,300 (98.5) 936.4 1,764,784 176478.4 (98.2) 335.1
Bacterial 21,955 1,689 (1.2) 11.9 20,337 2033.7 (1.1) 3.9
Protozoal 2,502 192 (0.1) 1.4 3,078 307.8 (0.2) 0.6
Rotavirus 303 23 (<0.1) 0.2 8,060 806 (0.4) 1.5
Adenovirus 464 36 (<0.1) 0.3 539 53.9 (<0.1) 0.1
Norovirus 435 33 (<0.1) 0.2 342 34.2 (<0.1) 0.1
All-cause
gastroenteritis
1,758,562 135,274 950.2 1,797,140 179,714 341.2
*Time period from July through June of the following year.
doi:10.1371/journal.pone.0148505.t002
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children with a median of 435 visits per 10,000 children (Fig 3). Norovirus-attributable
encounters accounted for 26.8–31.2% of cause-unspecified encounters among all age groups
and populations except for the 5–17 year age DB group, where it accounted for 54.1% of cause-
unspecified encounters (Table 3).
Additional exploratory analyses were performed aiming to identify drivers of incidence.
Based on models using monthly (rather than weekly) data, we estimated means of 226 (95%
CI: 162 to 290) and 71 (95% CI: 51 to 90) norovirus encounters per 10,000 members of the AD
and DB populations, respectively. This constituted 23% and 24% fewer norovirus-attributable
encounters in the AD population and DB population, respectively, compared to estimates
derived from weekly models. Next, models were run separately for weekly data from active
duty members who were<20 years old and40 years old. Throughout the study period, rates
of estimated norovirus visits in the<20 year-old age group (seasonal year range: 248–437
Fig 1. Cause-unspecified and estimated norovirus-attributable encounters by week. (A) Cause-unspecified and estimated norovirus-attributable
encounters by week among USmilitary active duty members, July 1998–June 2011. (B) Cause-unspecified and estimated norovirus-attributable encounters
by week among dependent beneficiaries of US military active duty members, July 2001–June 2011.
doi:10.1371/journal.pone.0148505.g001
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encounters per 10,000 persons) were consistently higher than those in the40 year-old age
group (seasonal year range: 116–229 encounters per 10,000 persons).
Finally, estimates of norovirus-attributable encounters were averaged by the week number
of the seasonal year over each population’s respective study period and plotted using a 5-week
moving average (Fig 4). Norovirus encounters exhibited a winter seasonality that was consis-
tent across populations and age groups. The strongest correlations were for un-lagged data:
norovirus activity was synchronized across the age groups (Table B in S1 File).
Table 3. All-cause, cause-unspecified (CU) and norovirus-attributable encounters by age group.
Population Seasonal
years*
Age
Group,
Years
All-Cause Encounters,
N (% of All Ages)
CU Encounters, N
(% of All Ages)
Norovirus-attributable
Encounters, N (% of All
Ages) †
Norovirus-
attributable/CU, %
Active Duty July 1998–
June 2011
All Ages 1,758,562 (100) 1,732,903 (100) 540,377 (100) 31.2
Dependent
Beneﬁciary
July 2001–
June 2011
0–4 969,093 (53.9) 952,063 (53.9) 254,925 (52.1) 26.8
Dependent
Beneﬁciary
July 2001–
June 2011
5–17 326,047 (18.1) 320,984 (18.2) 173,786 (35.5) 54.1
Dependent
Beneﬁciary
July 2001–
June 2011
18–39 440,520 (24.5) 432,144 (24.5) 116,303 (23.8) 26.9
Dependent
Beneﬁciary
July 2001–
June 2011
40–64 60,945 (3.4) 59,119 (3.3) 16,905 (3.5) 28.6
Dependent
Beneﬁciary
July 2001–
June 2011
All Ages 1,797,140 (100) 1,764,784 (100) 489,381 (100) 27.7
*Time period from July through June of the following year.
†Age-speciﬁc dependent beneﬁciary estimates were generated by separate models and do not sum to the All Ages estimate.
doi:10.1371/journal.pone.0148505.t003
Table 4. Norovirus-attributable encounters by season and population.
Seasonal Year* Active Duty Encounters Dependent Beneﬁciary Encounters (All Ages)
N† (95% CI‡) per 10,000 Persons (95% CI) N† (95% CI‡) per 10,000 Persons (95% CI)
98–99 51,200 (45,700–56,700) 364 (325–403)
99–00 25,800 (21,200–30,400) 185 (152–218)
00–01 32,700 (28,200–37,300) 234 (202–267)
01–02 23,700 (18,200–29,200) 168 (129–207) 34,000 (27,400–40,500) 66 (53–79)
02–03 55,100 (50,900–59,400) 382 (353–412) 52,000 (45,200–58,800) 98 (85–111)
03–04 43,200 (38,800–47,600) 297 (267–327) 42,900 (36,200–49,600) 80 (68–93)
04–05 53,200 (48,400–57,900) 370 (338–403) 72,800 (66,200–79,400) 139 (126–151)
05–06 41,100 (36,500–45,600) 292 (259–324) 48,300 (41,500–55,200) 93 (80–106)
06–07 47,600 (43,000–52,200) 339 (306–372) 48,600 (41,800–55,500) 94 (81–107)
07–08 54,300 (49,300–59,200) 387 (352–422) 55,400 (49,600–61,300) 107 (95–118)
08–09 32,300 (27,200–37,300) 225 (190–260) 43,900 (37,400–50,300) 83 (71–95)
09–10 48,300 (43,200–53,300) 332 (297–367) 43,400 (36,900–50,000) 81 (69–93)
10–11 32,000 (26,400–37,500) 219 (181–257) 48,000 (41,000–55,000) 89 (76–102)
Yearly Average 41,600 (36,700–46,400) 292 (258–326) 48,900 (42,300–55,600) 93 (80–105)
*Time period from July through June of the following year.
†Number of visits rounded to nearest 100.
‡Seasonal 95% conﬁdence intervals calculated by summing up weekly lower and upper bound estimates by season.
doi:10.1371/journal.pone.0148505.t004
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Fig 2. Norovirus-attributable encounters per 10,000 USmilitary active duty (AD) members and their dependent beneficiaries (DB) by seasonal
year, July 1998–June 2011.
doi:10.1371/journal.pone.0148505.g002
Fig 3. Median seasonal year norovirus-attributable encounters per 10,000 beneficiary persons by age
group (with ranges), July 2001–June 2011.
doi:10.1371/journal.pone.0148505.g003
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Discussion
We estimated 292 and 93 norovirus-attributable encounters per 10,000 persons per seasonal
year for the AD and DB populations, respectively, corresponding to an annual estimate of
~42,000 and ~49,000 AD and DB encounters, respectively. Norovirus-attributable encounters
represent 31% and 27% of all-cause gastroenteritis visits in the AD and DB populations, respec-
tively, highlighting the importance of norovirus as a cause of gastroenteritis in these settings.
Our estimates are consistent with what is known about norovirus epidemiology, with peak of
activity occurring in the winter [2, 17, 23–25]. In addition, rates were substantially higher
among children<5 years of age compared to other age groups, even when accounting for rota-
virus-coded visits [4, 7, 26].
Fig 4. Weekly percent of total norovirus-attributable medical encounters; 5-weekmoving average by week of year and population. The percentage
of estimated norovirus-attributable medical encounters for each week of the year were calculated for each population/age group as follows: the number of
encounters occurring in a given week was averaged over the entire study period for each respective group, then expressed as a percentage of the sum of all
weekly averages for that population/age group. Five-week moving averages of these values were calculated and plotted for each population/age group. AD:
Active duty; DB: Dependent beneficiary; age group range in years.
doi:10.1371/journal.pone.0148505.g004
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While sharing these general features with non-DoD population-based studies, our estimates
for medically-attended norovirus were higher than rates reported previously [27], including
the 64 (90% CI: 36–120) norovirus visits per 10,000 persons based on selective testing of mem-
bers of a health maintenance organization in the state of Georgia in 2004–05 [2] or the 57 (95%
CI: 40–74) per 10,000 persons in the US in 2001–09 based on a similar modeling approach
using national insurance claim databases, in which the proportion of cause-unspecified
encounters (95–97%) were similar to that seen in our population [7]. Studies in European pop-
ulations have produced comparable estimates ranging from 21 (95% CI: 14–30) to 92 (95% CI:
50–150) outpatient visits per 10,000 persons [4, 26, 28, 29]. Our estimate of 435 norovirus visits
per seasonal year among children<5 years of age were also higher than previous civilian esti-
mates based on active surveillance of children<5 years of age in three US counties (319 visits
per 10,000 children<5 years of age) [17], extrapolation from a systematic review (167 outpa-
tient visits per 10,000 children) [30] or statistical regression modeling (233 outpatient visits per
10,000 children [95% CI: 156–310]) [7].
We considered several hypotheses as to why our estimates were higher than previous
reports in civilian populations. First, our assumption that all residual seasonality was due to
norovirus may have overestimated the number of norovirus encounters since there are other
viral etiologies of acute gastroenteritis that have winter seasonality such as astrovirus, sapo-
virus, and rotavirus. However, astrovirus and sapovirus occur at substantially lower levels than
norovirus, as does adenovirus [2, 3, 31]. We accounted for rotavirus in all models as it is a
major cause of gastroenteritis, particularly in those<5 years of age. Although rotavirus-coded
encounters have been shown to only comprise a small minority of viral encounters in the active
duty population [32], our modeling approach attributed a substantial fraction of acute gastro-
enteritis to rotavirus in all age groups except in adult dependent beneficiaries. When explicitly
accounting for rotavirus in our model, no appreciable decline in estimated norovirus encoun-
ters was observed after 2006, the year rotavirus vaccine was introduced in the US.
Another factor potentially contributing to overestimation was the use of weekly count data,
in contrast to monthly intervals used by Gastañaduy et al [7]. It was expected that weekly data
would lead to greater variability in the model residuals, yielding a minimum residual of lower
magnitude than would be expected using monthly data with less variability; as a result, our esti-
mates based on weekly data would be expected to be higher. We observed this phenomenon in
a sensitivity analysis in which collapsing weekly data into months yielded lower estimates.
Although the revised estimates for the DB population more closely approximated previously
reported estimates [2, 7], the revised estimate for the AD population remained markedly
higher.
Given that these methodological biases may not completely explain higher rates of medi-
cally-attended norovirus, especially among the active duty military population, it remains pos-
sible that active duty personnel and their beneficiaries genuinely have greater care-seeking
and/or disease risk. Compared to the general civilian population, DoD service members and
their dependent families have increased access to high quality free medical care, likely leading
to increased utilization for a range of health concerns [33]. That our estimates for medically-
attended norovirus were lower than community incidence estimates for the US civilian popula-
tion (ranging from 650 [90% CI: 370–1200] [2] to 698 [90% CI: 430–1028] norovirus illnesses
per 10,000 persons [5]) suggests greater care-seeking as a plausible explanation. Military per-
sonnel may also be subject to higher disease rates as they are more likely to work and live in
close quarters and shared common spaces, factors that facilitate norovirus transmission. We
attempted to assess this by comparing incidence of norovirus-attributable encounters between
the<20 year-old age group and the40 year-old age group. We hypothesized that the rates of
norovirus visits would be higher among those<20 years of age who, as lower-ranked members,
Norovirus-Associated Medical Encounters
PLOS ONE | DOI:10.1371/journal.pone.0148505 April 26, 2016 10 / 14
are more likely to live and work with others in shared confined settings. In contrast, those40
years of age are more likely to be more senior in rank and comparatively spend less time in
shared confined spaces. We found that rates of estimated norovirus visits among those<20
years old were consistently higher than those40 years old throughout the study period, sup-
porting this hypothesis.
Other limitations of our study should be considered in addition to the considerations for
overestimation mentioned above. The statistical method assumes that coding and testing prac-
tices did not change over time. We addressed this possibility by adding a time variable to
account for any secular changes over the study period. In addition, our analyses used counts of
diagnostic codes to provide estimates that assumed one diagnostic code per visit. However, we
could not account for the possibility of medical encounters that had more than one associated
code, which may have also led to overestimation. Next, a minority (<15%) of all coded medical
encounters were known to occur outside of the continental US (data not shown). In principle,
their inclusion could have resulted in a dilution of the seasonality of AGE. However, model
residuals still exhibited a clear wintertime seasonality consistent with norovirus activity
observed in the continental US (Fig 1). Underestimation of norovirus disease was also possible,
as we assumed that no norovirus visits occurred in one week of the year, whereas norovirus is
known to circulate year-round [2, 17, 25]. Finally, although we found no evidence of temporal
variability in norovirus activity across age groups suggesting that one age group spread infec-
tion to another, our study did not evaluate questions such as service-specific rates of norovirus
disease, spatiotemporal dynamics of norovirus disease, or specifying illnesses in deployed pop-
ulations. In particular, deployed personnel could not be differentiated from non-deployed per-
sonnel in our model due to the aggregate nature of both the medical encounter and total
enrollment data. Additional studies may help better evaluate the impact norovirus disease has
on cost, lost productivity, and potential mission impact among US DoD populations.
While the full impact of norovirus disease on the US military is still to be quantified, our
results highlight the importance of norovirus as a cause of infectious gastroenteritis among
active duty military personnel and their beneficiaries in non-deployment settings. Active sur-
veillance studies using sensitive clinical diagnostics for norovirus would help further solidify
estimates of the burden of disease in military populations. Risk factor studies among AD and
DB could improve our understanding of the epidemiology of norovirus and elucidate why
rates are apparently higher in these populations. Finally, our results point to the potential bene-
fits of vaccines, which are currently in development, and establish baseline estimates with
which to evaluate the value of such an intervention [34, 35].
Notes
1. The views expressed in this article are those of the authors and do not necessarily reflect the
official policy or position of the Department of the Navy, Department of Defense, nor the
U.S. Government.
2. Two of the authors (MR and CP) are military service members and employees of the U.S.
Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105
provides that ‘Copyright protection under this title is not available for any work of the
United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work
prepared by a military service member or employee of the U.S. Government as part of that
person’s official duties.
3. Results of preliminary analysis of this data was presented as an abstract at the Vaccines for
Enteric Diseases (VED 2015) Conference in Edinburgh, UK, July 8–10, 2015.
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